• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

针对新出现的H5N1高致病性禽流感病毒疫情的有效疫苗的大流行防范。

Pandemic preparedness of effective vaccines for the outbreak of newly H5N1 highly pathogenic avian influenza virus.

作者信息

Gao Feixia, Wang Qi, Qiu Chenchen, Luo Jian, Li Xiuling

机构信息

Shanghai Institute of Biological Products, 200052, Shanghai, China.

Shanghai Institute of Biological Products, 200052, Shanghai, China.

出版信息

Virol Sin. 2024 Dec;39(6):981-985. doi: 10.1016/j.virs.2024.11.005. Epub 2024 Nov 30.

DOI:10.1016/j.virs.2024.11.005
PMID:39622294
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11738761/
Abstract

• Analyzed the outbreak situation and viral characteristics of the newly H5N1 highly pathogenic avian influenza (HPAI) virus. • The current approval and research and development of the H5N1 HPAI vaccines were summarized. • Proposed vaccine development approaches against newly H5N1 virus, e.g. adjuvanted vaccine, mRNA vaccine, multivalent vaccine. • Discussed other prevention and control strategies, e.g. poultry vaccination, global surveillance and comprehensive testing.

摘要

• 分析了新型H5N1高致病性禽流感（HPAI）病毒的暴发情况和病毒特征。

• 总结了H5N1 HPAI疫苗目前的获批情况及研发进展。

• 提出了针对新型H5N1病毒的疫苗研发方法，如佐剂疫苗、mRNA疫苗、多价疫苗。

• 讨论了其他防控策略，如家禽疫苗接种、全球监测和全面检测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/096c/11738761/597fe8e41d6e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/096c/11738761/597fe8e41d6e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/096c/11738761/597fe8e41d6e/gr1.jpg

相似文献

1
Pandemic preparedness of effective vaccines for the outbreak of newly H5N1 highly pathogenic avian influenza virus.针对新出现的H5N1高致病性禽流感病毒疫情的有效疫苗的大流行防范。
Virol Sin. 2024 Dec;39(6):981-985. doi: 10.1016/j.virs.2024.11.005. Epub 2024 Nov 30.
2
Cross-Protection by Inactivated H5 Prepandemic Vaccine Seed Strains against Diverse Goose/Guangdong Lineage H5N1 Highly Pathogenic Avian Influenza Viruses.灭活 H5 疫苗种株对不同鸭/广东谱系 H5N1 高致病性禽流感病毒的交叉保护作用。
J Virol. 2020 Nov 23;94(24). doi: 10.1128/JVI.00720-20.
3
Bivalent Hemagglutinin Cleavage-Site Peptide Vaccines Protect Chickens from Lethal Infections with Highly Pathogenic H5N1 and H5N6 Avian Influenza Viruses.二价血凝素裂解位点肽疫苗可预防高致病性 H5N1 和 H5N6 禽流感病毒对鸡的致死性感染。
Front Biosci (Landmark Ed). 2024 Feb 6;29(2):61. doi: 10.31083/j.fbl2902061.
4
The panzootic spread of highly pathogenic avian influenza H5N1 sublineage 2.3.4.4b: a critical appraisal of One Health preparedness and prevention.高致病性禽流感 H5N1 亚系 2.3.4.4b 的泛发性传播：对“同一健康”防备和预防的批判性评估。
Lancet Infect Dis. 2024 Dec;24(12):e774-e781. doi: 10.1016/S1473-3099(24)00438-9. Epub 2024 Aug 9.
5
Intranasal administration of a live non-pathogenic avian H5N1 influenza virus from a virus library confers protective immunity against H5N1 highly pathogenic avian influenza virus infection in mice: comparison of formulations and administration routes of vaccines.鼻腔内给予病毒文库中的活非致病性禽流感 H5N1 病毒可使小鼠对 H5N1 高致病性禽流感病毒感染产生保护免疫：疫苗制剂和给药途径的比较。
Vaccine. 2009 Dec 9;27(52):7402-8. doi: 10.1016/j.vaccine.2009.08.089. Epub 2009 Sep 10.
6
The next influenza pandemic: lessons from Hong Kong.下一次流感大流行：香港的经验教训。
J Appl Microbiol. 2003;94 Suppl:70S-79S. doi: 10.1046/j.1365-2672.94.s1.8.x.
7
Virus-like particle vaccine comprised of the HA, NA, and M1 proteins of an avian isolated H5N1 influenza virus induces protective immunity against homologous and heterologous strains in mice.由禽源H5N1流感病毒的血凝素（HA）、神经氨酸酶（NA）和基质蛋白1（M1）组成的病毒样颗粒疫苗可诱导小鼠对同源和异源毒株产生保护性免疫。
Viral Immunol. 2009 Jul;22(4):273-81. doi: 10.1089/vim.2009.0017.
8
Induction of cytotoxic T-lymphocyte and antibody responses against highly pathogenic avian influenza virus infection in mice by inoculation of apathogenic H5N1 influenza virus particles inactivated with formalin.通过接种经福尔马林灭活的无致病性H5N1流感病毒颗粒诱导小鼠针对高致病性禽流感病毒感染产生细胞毒性T淋巴细胞和抗体反应。
Immunology. 2008 Jun;124(2):155-65. doi: 10.1111/j.1365-2567.2007.02745.x. Epub 2008 Jan 16.
9
[Development of attenuated H5N1 avian influenza vaccines using reverse genetic technology].[利用反向遗传技术研发减毒H5N1禽流感疫苗]
Nihon Rinsho. 2006 Oct;64(10):1855-64.
10
Avian influenza virus infections in humans.人类感染禽流感病毒
Chest. 2006 Jan;129(1):156-68. doi: 10.1378/chest.129.1.156.

引用本文的文献

1
Deficiency of IFNAR1 Increases the Production of Influenza Vaccine Viruses in MDCK Cells.IFNAR1缺陷增加了MDCK细胞中流感疫苗病毒的产量。
Viruses. 2025 Aug 8;17(8):1097. doi: 10.3390/v17081097.
2
Fast and flu-rious: How to prevent and treat emerging influenza A viruses.快速且肆虐：如何预防和治疗新出现的甲型流感病毒
PLoS Pathog. 2025 May 16;21(5):e1013135. doi: 10.1371/journal.ppat.1013135. eCollection 2025 May.
3
The emergence of highly pathogenic avian influenza H5N1 in dairy cattle: implications for public health, animal health, and pandemic preparedness.

本文引用的文献

1
A broad-spectrum vaccine candidate against H5 viruses bearing different sub-clade 2.3.4.4 HA genes.一种针对携带不同2.3.4.4亚分支HA基因的H5病毒的广谱候选疫苗。
NPJ Vaccines. 2024 Aug 19;9(1):152. doi: 10.1038/s41541-024-00947-4.
2
Licensed H5N1 vaccines generate cross-neutralizing antibodies against highly pathogenic H5N1 clade 2.3.4.4b influenza virus.经许可的 H5N1 疫苗可产生针对高致病性 H5N1 谱系 2.3.4.4b 流感病毒的交叉中和抗体。
Nat Med. 2024 Oct;30(10):2771-2776. doi: 10.1038/s41591-024-03189-y. Epub 2024 Jul 16.
3
Pandemic preparedness through vaccine development for avian influenza viruses.
高致病性H5N1禽流感病毒在奶牛中的出现：对公共卫生、动物健康和大流行防范的影响。
Eur J Clin Microbiol Infect Dis. 2025 May 14. doi: 10.1007/s10096-025-05147-z.
通过开发针对禽流感病毒的疫苗做好大流行的准备。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2347019. doi: 10.1080/21645515.2024.2347019. Epub 2024 May 28.
4
Development of a nucleoside-modified mRNA vaccine against clade 2.3.4.4b H5 highly pathogenic avian influenza virus.针对 2.3.4.4b 谱系 H5 高致病性禽流感病毒的核苷修饰 mRNA 疫苗的研制。
Nat Commun. 2024 May 23;15(1):4350. doi: 10.1038/s41467-024-48555-z.
5
Highly Pathogenic Avian Influenza A(H5N1) Virus Infection in a Dairy Farm Worker.一名奶农感染高致病性甲型禽流感（H5N1）病毒
N Engl J Med. 2024 Jun 6;390(21):2028-2029. doi: 10.1056/NEJMc2405371. Epub 2024 May 3.
6
Vaccination and Antiviral Treatment against Avian Influenza H5Nx Viruses: A Harbinger of Virus Control or Evolution.针对H5Nx禽流感病毒的疫苗接种与抗病毒治疗：病毒控制或进化的先兆
Vaccines (Basel). 2023 Oct 24;11(11):1628. doi: 10.3390/vaccines11111628.
7
Alarming situation of emerging H5 and H7 avian influenza and effective control strategies.令人担忧的 H5 和 H7 禽流感新发病况和有效控制策略。
Emerg Microbes Infect. 2023 Dec;12(1):2155072. doi: 10.1080/22221751.2022.2155072.
8
AddaVax-Adjuvanted H5N8 Inactivated Vaccine Induces Robust Humoral Immune Response against Different Clades of H5 Viruses.AddaVax佐剂H5N8灭活疫苗可诱导针对不同H5病毒分支的强大体液免疫反应。
Vaccines (Basel). 2022 Oct 9;10(10):1683. doi: 10.3390/vaccines10101683.
9
Epidemiologic, Clinical, and Genetic Characteristics of Human Infections with Influenza A(H5N6) Viruses, China.中国 A(H5N6)型流感病毒人感染的流行病学、临床和遗传学特征。
Emerg Infect Dis. 2022 Jul;28(7):1332-1344. doi: 10.3201/eid2807.212482. Epub 2022 Apr 27.
10
Avian Influenza A(H5N1) Virus in Egypt.埃及的甲型H5N1禽流感病毒
Emerg Infect Dis. 2016 Mar;22(3):379-88. doi: 10.3201/eid2203.150593.